Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",A1BG,Alpha-1B-glycoprotein,18511,1612,1.96 [1.45-2.64],1.0418045457706468e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",20784,1814,1.20 [1.14-1.26],3.123962945323044e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACE2,Angiotensin-converting enzyme 2,20906,1832,1.33 [1.23-1.43],2.3147430135304766e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,17944,1562,0.80 [0.72-0.90],8.867565893395803e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,21379,1864,1.48 [1.32-1.67],9.076164777272904e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACTA2,"Actin, aortic smooth muscle",20906,1832,1.21 [1.11-1.32],1.0076542569705308e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,21064,1844,2.02 [1.75-2.34],2.3684819650275854e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ACY1,Aminoacylase-1,21289,1860,1.24 [1.16-1.32],3.1558216846024776e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADA2,Adenosine deaminase 2,21179,1847,1.24 [1.13-1.37],1.1379649306487164e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,17944,1562,1.53 [1.34-1.73],5.1658756748244426e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,21104,1848,0.76 [0.69-0.85],1.1639210582921003e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,21450,1874,1.39 [1.21-1.60],2.466053094854432e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,18435,1602,1.45 [1.23-1.70],8.406358599984638e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,21556,1882,0.68 [0.57-0.80],7.467223832690105e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,21186,1853,1.25 [1.13-1.38],2.262159746094844e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,17944,1562,1.31 [1.16-1.48],2.4819241937815618e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,21352,1860,0.81 [0.74-0.89],6.4680187617462135e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,18498,1605,1.90 [1.68-2.15],4.01972361637824e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,17992,1559,1.52 [1.24-1.87],6.35088998570289e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,18077,1558,1.62 [1.46-1.79],6.888290629731606e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADIPOQ,Adiponectin,18511,1612,1.21 [1.13-1.29],6.950448691520471e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ADM,Pro-adrenomedullin,21472,1876,2.73 [2.32-3.20],3.138194425393302e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGR2,Anterior gradient protein 2 homolog,20683,1820,1.13 [1.09-1.18],9.150078293132504e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGRN,Agrin,21367,1868,1.43 [1.27-1.60],2.072431438897286e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AGXT,Serine--pyruvate aminotransferase,21289,1860,1.16 [1.10-1.23],2.60335210329976e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",21155,1849,1.09 [1.04-1.13],2.509615008677192e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",21245,1861,1.18 [1.12-1.25],2.7679149799066527e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",18454,1594,1.29 [1.17-1.43],2.410095846971856e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ALPP,"Alkaline phosphatase, placental type",21186,1853,1.22 [1.17-1.27],3.299437490661569e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMBP,Protein AMBP,21442,1872,1.66 [1.37-2.02],4.240980227603286e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AMOT,Angiomotin,18077,1558,0.73 [0.64-0.83],2.075559224832605e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANG,Angiogenin,21250,1853,1.43 [1.27-1.62],7.40823613036622e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPT2,Angiopoietin-2,21472,1876,1.71 [1.54-1.91],3.6876927756135547e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,20960,1825,1.42 [1.22-1.64],3.453100898271698e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,21336,1865,1.45 [1.33-1.59],2.840948787874009e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,21472,1876,1.34 [1.21-1.48],2.6255073334855685e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANPEP,Aminopeptidase N,21362,1861,1.57 [1.33-1.84],3.668369216129272e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ANXA10,Annexin A10,20838,1837,1.14 [1.08-1.20],4.801988668485044e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AOC3,Membrane primary amine oxidase,21393,1864,1.55 [1.35-1.79],1.6901454097263114e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",APLP1,Amyloid-like protein 1,21289,1860,0.78 [0.72-0.85],3.4291348850627316e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AREG,Amphiregulin,21186,1853,1.82 [1.65-2.00],4.6530930152885755e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,21104,1848,1.83 [1.63-2.05],1.34401330292528e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,18509,1603,1.91 [1.59-2.29],4.2801122262928135e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",AZU1,Azurocidin,20674,1799,1.11 [1.05-1.16],4.233192025043754e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B2M,Beta-2-microglobulin,18511,1612,1.50 [1.36-1.65],6.87375878651356e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",17992,1559,1.36 [1.19-1.55],4.221196329673823e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",21367,1868,1.40 [1.21-1.61],4.255145335272606e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,20784,1814,1.24 [1.16-1.32],1.8070495920122048e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BCAN,Brevican core protein,21104,1848,0.60 [0.53-0.67],5.8269219093180464e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BMPER,BMP-binding endothelial regulator protein,18077,1558,1.75 [1.41-2.19],5.343664129017388e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,17944,1562,1.25 [1.12-1.39],3.849624232986798e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BPIFB1,BPI fold-containing family B member 1,21257,1855,1.45 [1.36-1.54],3.2972043871775215e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BSG,Basigin,21507,1876,2.35 [1.94-2.85],4.141774820888349e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BST2,Bone marrow stromal antigen 2,21484,1876,1.54 [1.44-1.65],1.977130926780645e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,21367,1868,1.36 [1.17-1.59],7.512241956470324e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,21282,1863,1.30 [1.17-1.44],1.2810899006875658e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C19orf12,Protein C19orf12,20838,1837,1.15 [1.09-1.22],1.2108982999373887e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,21393,1864,1.32 [1.20-1.45],3.346860836105882e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",C7,Complement component C7,18066,1572,1.73 [1.49-2.01],1.1746575573131314e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA14,Carbonic anhydrase 14,21472,1876,0.73 [0.65-0.82],1.9789576215275853e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA4,Carbonic anhydrase 4,21556,1882,1.56 [1.33-1.83],7.191385787843766e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",20906,1832,1.13 [1.08-1.18],3.542801931835192e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA6,Carbonic anhydrase 6,21237,1860,0.80 [0.75-0.86],8.507789528294004e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CA9,Carbonic anhydrase 9,21472,1876,1.23 [1.12-1.35],8.155378398979193e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CALCB,Calcitonin gene-related peptide 2,18446,1599,1.29 [1.14-1.46],5.29457162160305e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CAPG,Macrophage-capping protein,21139,1848,1.21 [1.13-1.29],8.321952774160932e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CBLN4,Cerebellin-4,21472,1876,0.72 [0.63-0.81],2.9326122749190694e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,21289,1860,1.53 [1.36-1.72],1.2490322628452688e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL11,Eotaxin,21543,1879,1.30 [1.17-1.45],2.029251739360424e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL14,C-C motif chemokine 14,21250,1853,1.22 [1.11-1.34],5.784144901393654e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL15,C-C motif chemokine 15,21556,1882,1.31 [1.20-1.43],1.518733798122927e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL16,C-C motif chemokine 16,21556,1882,1.23 [1.13-1.34],6.03087775610622e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL17,C-C motif chemokine 17,21218,1857,1.14 [1.09-1.18],4.378527449682512e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL18,C-C motif chemokine 18,21021,1836,1.13 [1.07-1.19],1.370629231624197e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL19,C-C motif chemokine 19,21484,1876,1.08 [1.05-1.11],1.6431450216605082e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL20,C-C motif chemokine 20,21543,1879,1.22 [1.17-1.28],6.390314245826694e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL21,C-C motif chemokine 21,21367,1868,1.51 [1.40-1.62],4.950218137326337e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL22,C-C motif chemokine 22,21047,1838,1.37 [1.27-1.48],9.791018864175656e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL23,C-C motif chemokine 23,21367,1868,1.26 [1.15-1.39],2.225322946250424e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL25,C-C motif chemokine 25,21543,1879,1.22 [1.12-1.32],1.5045016956453951e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL27,C-C motif chemokine 27,21289,1860,1.17 [1.10-1.25],3.10074680947737e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL28,C-C motif chemokine 28,21214,1855,1.19 [1.12-1.27],2.2532811876481163e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL3,C-C motif chemokine 3,21282,1863,1.15 [1.09-1.20],9.518370925643845e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL5,C-C motif chemokine 5,21393,1864,1.09 [1.05-1.14],1.884146434255438e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCL7,C-C motif chemokine 7,21282,1863,1.24 [1.17-1.32],4.286473146922877e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN1,CCN family member 1,21156,1849,1.13 [1.07-1.19],2.70998473957162e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN3,CCN family member 3,21515,1875,1.30 [1.15-1.48],2.7686114454956108e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CCN4,CCN family member 4,21472,1876,1.27 [1.14-1.41],9.89938742742748e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD101,Immunoglobulin superfamily member 2,18435,1602,1.29 [1.14-1.45],2.44388288247504e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD14,Monocyte differentiation antigen CD14,20900,1824,1.61 [1.46-1.78],4.239575839073812e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,21393,1864,1.33 [1.22-1.46],3.3524095118553357e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD248,Endosialin,18498,1605,0.78 [0.70-0.87],7.339559685674736e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD27,CD27 antigen,21352,1860,1.51 [1.37-1.66],3.275283265475432e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD274,Programmed cell death 1 ligand 1,21104,1848,1.47 [1.30-1.67],1.1900066638151935e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300C,CMRF35-like molecule 6,21484,1876,1.45 [1.29-1.62],2.095715943286578e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300E,CMRF35-like molecule 2,21413,1871,1.45 [1.31-1.60],1.6834662119681358e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD300LF,CMRF35-like molecule 1,21472,1876,1.21 [1.13-1.30],1.239775113234038e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD302,CD302 antigen,21186,1853,1.67 [1.47-1.91],6.710480674587462e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD4,T-cell surface glycoprotein CD4,21251,1857,1.52 [1.33-1.75],2.114858617958854e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,21262,1859,1.21 [1.12-1.31],3.557697478406411e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD59,CD59 glycoprotein,20545,1789,1.52 [1.28-1.82],2.587344988479955e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD7,T-cell antigen CD7,17915,1559,1.29 [1.16-1.43],2.725556337701688e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD70,CD70 antigen,21282,1863,1.21 [1.10-1.33],7.981372768116404e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,21484,1876,1.56 [1.38-1.75],1.0764279606386841e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD80,T-lymphocyte activation antigen CD80,18494,1603,1.57 [1.37-1.81],2.8421592913384103e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD83,CD83 antigen,21282,1863,1.64 [1.48-1.81],5.649205006059136e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CD99L2,CD99 antigen-like protein 2,21302,1865,1.95 [1.65-2.31],4.664287752961446e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDCP1,CUB domain-containing protein 1,21104,1848,1.40 [1.31-1.50],2.3998148989952578e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH1,Cadherin-1,20587,1798,1.22 [1.11-1.35],2.8856562582246084e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDH2,Cadherin-2,21289,1860,1.43 [1.28-1.60],6.903673526652141e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CDHR2,Cadherin-related family member 2,21186,1853,1.14 [1.07-1.21],6.400469450469807e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,21322,1858,2.54 [2.10-3.07],8.2483283419173745e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,18435,1602,0.72 [0.68-0.76],2.0811687772805564e-32
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,20519,1790,1.44 [1.36-1.52],4.334233778645655e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,18498,1605,1.51 [1.34-1.70],4.604696158813423e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,20906,1832,1.30 [1.20-1.40],1.5869315465689658e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,18498,1605,1.20 [1.12-1.29],3.223334359121478e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CES1,Liver carboxylesterase 1,21353,1863,1.15 [1.09-1.20],1.0249138270281496e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFB,Complement factor B,18203,1588,1.79 [1.54-2.08],6.317554094460818e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFD,Complement factor D,18511,1612,1.62 [1.31-2.02],1.0293817837436744e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFH,Complement factor H,17473,1531,1.70 [1.37-2.11],1.795539526503076e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CFI,Complement factor I,18511,1612,2.27 [1.77-2.92],1.1684618234970919e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CGA,Glycoprotein hormones alpha chain,21302,1865,1.25 [1.17-1.33],2.4804245886881303e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",18446,1599,1.58 [1.41-1.76],1.522802112825349e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHCHD6,MICOS complex subunit MIC25,18419,1587,1.73 [1.50-2.01],1.45404361485121e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHGA,Chromogranin-A,18498,1605,1.17 [1.11-1.24],1.418214618170539e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHI3L1,Chitinase-3-like protein 1,20839,1815,1.33 [1.28-1.39],4.871367700778677e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CHRDL1,Chordin-like protein 1,21336,1865,1.45 [1.28-1.65],1.1325166801971036e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CILP,Cartilage intermediate layer protein 1,18498,1605,1.30 [1.19-1.42],9.171838137420558e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,21433,1870,1.62 [1.44-1.82],2.116534269411745e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CKB,Creatine kinase B-type,18498,1605,1.36 [1.25-1.47],1.9752035136050842e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,21104,1848,1.36 [1.22-1.53],9.962144675433328e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,21302,1865,1.46 [1.28-1.65],5.721742278522519e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC3B,Tetranectin,18107,1578,0.60 [0.48-0.76],1.4614541354730328e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,21282,1863,1.31 [1.24-1.38],3.1781733694355624e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,21214,1853,1.81 [1.61-2.03],1.4457474945221573e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,20784,1814,1.30 [1.20-1.41],9.349661119767828e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLGN,Calmegin,18001,1566,1.28 [1.17-1.40],1.8877391969486085e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLMP,CXADR-like membrane protein,21472,1876,1.69 [1.40-2.03],3.2755072414210256e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CLSTN2,Calsyntenin-2,21543,1879,1.39 [1.26-1.54],6.840326417751277e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN1,Contactin-1,21556,1882,0.64 [0.55-0.74],2.1178197187481403e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CNTN5,Contactin-5,21344,1865,0.74 [0.66-0.83],2.081944125459691e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,21379,1865,2.26 [1.89-2.70],3.07084959473373e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,21289,1860,1.40 [1.26-1.55],2.4599659002019116e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL5A1,Collagen alpha-1(V) chain,18077,1558,1.32 [1.17-1.48],8.493035540814105e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,21556,1882,1.54 [1.38-1.73],1.081128934547662e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COLEC12,Collectin-12,21262,1860,1.70 [1.46-1.98],3.601432770093104e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",17992,1559,1.26 [1.13-1.42],5.3062966535398207e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPA1,Carboxypeptidase A1,21556,1882,1.17 [1.11-1.24],1.5867327175233264e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPB1,Carboxypeptidase B,21556,1882,1.14 [1.07-1.22],4.3405447134271024e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPM,Carboxypeptidase M,21373,1862,1.39 [1.23-1.56],4.980254865607672e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,21428,1871,1.23 [1.11-1.36],7.457810483324264e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CREG1,Protein CREG1,21021,1832,1.42 [1.30-1.55],5.301848940107103e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,21262,1860,1.49 [1.28-1.73],1.971093500102148e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,21367,1868,1.64 [1.33-2.02],3.2746022752650365e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CRIP2,Cysteine-rich protein 2,21104,1848,1.26 [1.13-1.40],4.53916637657646e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,21367,1868,1.55 [1.34-1.79],2.232348856039536e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,17944,1562,1.38 [1.18-1.62],6.881685533876112e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST3,Cystatin-C,21354,1860,1.69 [1.46-1.96],1.3377699849772708e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CST7,Cystatin-F,21293,1862,1.11 [1.07-1.16],4.290863218298733e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CSTB,Cystatin-B,21003,1829,1.33 [1.21-1.46],1.9879303655653486e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,18498,1605,1.48 [1.25-1.76],5.583346735556716e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSB,Cathepsin B,21308,1858,1.17 [1.08-1.26],6.67338110244078e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSC,Dipeptidyl peptidase 1,21215,1858,1.23 [1.13-1.35],5.126796964459806e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSD,Cathepsin D,19923,1746,1.60 [1.49-1.72],3.811023792171941e-37
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSF,Cathepsin F,21352,1860,1.31 [1.19-1.44],3.4155759249838056e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSL,Cathepsin L1,21289,1860,1.51 [1.28-1.79],1.5448624215213983e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSO,Cathepsin O,21543,1879,1.31 [1.16-1.47],8.461703504550805e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CTSZ,Cathepsin Z,21328,1859,1.42 [1.25-1.61],7.253866889562234e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,21282,1863,1.52 [1.41-1.64],6.392150751524309e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL11,C-X-C motif chemokine 11,21484,1876,1.11 [1.06-1.16],3.166460934136106e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL12,Stromal cell-derived factor 1,20914,1833,1.25 [1.13-1.39],2.3301617112224253e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL16,C-X-C motif chemokine 16,21521,1879,1.94 [1.63-2.31],5.6136324297638343e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL17,C-X-C motif chemokine 17,21543,1879,1.88 [1.77-2.00],3.275049089443917e-89
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL8,Interleukin-8,21138,1850,1.15 [1.09-1.21],2.20305786372384e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",CXCL9,C-X-C motif chemokine 9,21367,1868,1.20 [1.13-1.27],1.7996934554018071e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",21352,1860,1.32 [1.17-1.48],4.618363738361272e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",21186,1853,1.35 [1.24-1.47],5.539014499564652e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,21484,1876,1.93 [1.65-2.26],3.8775744660822236e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLK1,Protein delta homolog 1,21556,1882,0.83 [0.78-0.89],3.511883536562847e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DLL1,Delta-like protein 1,21352,1860,1.36 [1.19-1.55],6.6259219011472746e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,17992,1559,0.83 [0.76-0.90],4.927662397022356e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,21282,1863,1.53 [1.39-1.69],1.9517218339687493e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,21186,1853,0.73 [0.64-0.82],3.931794603734336e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPP7,Dipeptidyl peptidase 2,21129,1847,1.30 [1.21-1.38],1.9196704211169163e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DPY30,Protein dpy-30 homolog,21415,1872,1.17 [1.10-1.25],9.158952307125282e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTNB,Dystrobrevin beta,18380,1585,1.28 [1.15-1.42],4.389778480473695e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,21186,1853,1.59 [1.37-1.84],6.959410528649593e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",18494,1603,1.26 [1.19-1.33],5.150013950349291e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",17992,1559,1.14 [1.09-1.20],2.130906787763486e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,21472,1876,1.39 [1.25-1.55],1.664949468008948e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,20906,1832,1.44 [1.31-1.58],3.0400917572590486e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EDN1,Endothelin-1,17992,1559,2.09 [1.79-2.45],6.817887864573586e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,21359,1861,1.45 [1.28-1.65],1.1604234946054592e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA1,Ephrin-A1,21263,1858,1.73 [1.50-1.99],1.6698148874377204e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EFNA4,Ephrin-A4,21064,1844,1.64 [1.45-1.85],2.5360025392767626e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,20784,1814,1.34 [1.20-1.48],7.226170269304914e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGFR,Epidermal growth factor receptor,21556,1882,0.44 [0.34-0.56],1.4448673519075063e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EGLN1,Egl nine homolog 1,21282,1863,1.17 [1.11-1.24],7.3609377546572706e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,21289,1860,1.15 [1.09-1.23],4.190329734937211e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ELN,Elastin,18494,1603,1.39 [1.21-1.60],3.114330645074164e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,21367,1868,0.79 [0.73-0.85],1.695822192445541e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,20647,1804,1.22 [1.16-1.28],4.566957854157812e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,20784,1814,1.21 [1.10-1.33],4.734962329870297e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHA2,Ephrin type-A receptor 2,20504,1782,1.47 [1.29-1.68],5.125641405220269e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPHB4,Ephrin type-B receptor 4,21556,1882,1.41 [1.20-1.66],2.37741017279423e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,21439,1873,1.50 [1.32-1.70],5.895328436939694e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,21352,1860,1.75 [1.49-2.07],2.809173002572884e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",EZR,Ezrin,21484,1876,1.48 [1.27-1.72],4.98361945863919e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",F9,Coagulation factor IX,21360,1861,1.99 [1.57-2.52],9.531242116824029e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP1,"Fatty acid-binding protein, liver",21262,1860,1.18 [1.14-1.23],4.769192859970308e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP3,"Fatty acid-binding protein, heart",18494,1603,1.21 [1.11-1.32],1.101139333144466e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",21556,1882,1.42 [1.31-1.54],1.1436300237805492e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FABP5,Fatty acid-binding protein 5,21410,1872,1.15 [1.09-1.22],1.7802970003250555e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM20A,Pseudokinase FAM20A,18494,1603,2.03 [1.76-2.34],6.42052920738819e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3B,Protein FAM3B,21186,1853,1.35 [1.20-1.52],6.690515029125384e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FAM3C,Protein FAM3C,21260,1858,1.44 [1.25-1.65],2.927539378246036e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,21543,1879,0.75 [0.68-0.83],2.1466382211993644e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,21282,1863,1.19 [1.10-1.30],5.4794457584795634e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCN1,Ficolin-1,18480,1603,1.41 [1.28-1.54],1.3448471618544e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FCRLB,Fc receptor-like B,20784,1814,1.18 [1.10-1.25],4.361862098445488e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGA,Fibrinogen alpha chain,18100,1579,1.65 [1.41-1.93],2.9499321277154863e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF21,Fibroblast growth factor 21,21448,1875,1.24 [1.21-1.28],2.222465660101435e-50
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF23,Fibroblast growth factor 23,21433,1872,1.30 [1.22-1.39],3.9339001466816695e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGF5,Fibroblast growth factor 5,20914,1833,1.28 [1.13-1.45],6.105854408007679e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,21352,1860,0.79 [0.71-0.89],6.077750580450361e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,21352,1860,1.93 [1.61-2.31],1.6642824732183982e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FGL1,Fibrinogen-like protein 1,18509,1603,1.36 [1.27-1.46],3.4234819349577705e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FIS1,Mitochondrial fission 1 protein,21253,1858,1.12 [1.06-1.18],1.764531988104242e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FST,Follistatin,21336,1865,1.29 [1.19-1.40],8.126154594804264e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL1,Follistatin-related protein 1,17992,1559,1.93 [1.56-2.38],1.0109034943845634e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FSTL3,Follistatin-related protein 3,21234,1859,2.00 [1.78-2.26],5.7320351072475696e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUOM,Fucose mutarotase,18077,1558,1.18 [1.10-1.28],1.765143546141388e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FURIN,Furin,21352,1860,1.49 [1.32-1.68],4.6671324327282766e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,21484,1876,1.46 [1.34-1.59],5.73592040288285e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAL,Galanin peptides,21367,1868,0.86 [0.81-0.92],2.157813314567233e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,21186,1853,1.65 [1.43-1.91],6.7875420023001755e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,21472,1876,0.69 [0.60-0.81],2.817501845661146e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAS6,Growth arrest-specific protein 6,21422,1870,1.60 [1.36-1.89],1.05820535588202e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GAST,Gastrin,18446,1599,1.14 [1.10-1.18],3.4151348196417936e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,17628,1527,1.35 [1.25-1.46],1.549766576946533e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GDF15,Growth/differentiation factor 15,21556,1882,1.87 [1.74-2.01],3.3794484203003573e-65
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,20784,1814,1.20 [1.12-1.27],1.5771202576534942e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRA1,GDNF family receptor alpha-1,21448,1875,1.76 [1.52-2.03],1.0407044916291436e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GFRAL,GDNF family receptor alpha-like,17928,1551,0.79 [0.73-0.86],3.778159743738788e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,21263,1858,1.52 [1.41-1.63],4.233668379514344e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,21104,1848,1.82 [1.55-2.14],6.078900160340499e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,18446,1599,1.54 [1.34-1.77],2.007598310378864e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLA,Alpha-galactosidase A,18046,1554,1.32 [1.17-1.50],8.852766531778585e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLB1,Beta-galactosidase,21104,1848,1.21 [1.11-1.33],4.760923898999434e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GLO1,Lactoylglutathione lyase,20906,1832,1.22 [1.14-1.32],3.0870429410318184e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GM2A,Ganglioside GM2 activator,18049,1563,1.32 [1.16-1.51],3.1370733896826285e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GOLM2,Protein GOLM2,21484,1876,1.75 [1.45-2.10],3.1757904231089063e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPC5,Glypican-5,21104,1848,0.86 [0.80-0.92],4.243432110470191e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,18419,1587,1.29 [1.19-1.41],2.117589489337127e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,20838,1837,1.34 [1.20-1.49],1.6309334394948284e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPR37,Prosaposin receptor GPR37,20906,1832,1.28 [1.20-1.37],1.1121950813652836e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,18419,1587,1.34 [1.25-1.45],2.87216090188439e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRN,Progranulin,21191,1854,1.71 [1.47-2.00],1.0394122934355395e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",21186,1853,1.36 [1.28-1.44],3.4102852617392656e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GSN,Gelsolin,18433,1597,0.47 [0.36-0.61],1.1036694050966376e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",GUSB,Beta-glucuronidase,21379,1864,1.19 [1.11-1.27],5.618940256335535e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAO1,Hydroxyacid oxidase 1,21472,1876,1.10 [1.06-1.13],2.3655327809943092e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,21442,1872,1.38 [1.30-1.46],6.207107131494159e-27
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,21302,1865,1.60 [1.43-1.79],5.455832177574557e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HEG1,Protein HEG homolog 1,18077,1558,1.79 [1.52-2.12],7.247215872842079e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HGF,Hepatocyte growth factor,21543,1879,1.74 [1.57-1.94],7.148981022630269e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,18409,1595,1.25 [1.16-1.35],1.242425338952074e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HJV,Hemojuvelin,18454,1594,1.25 [1.12-1.40],6.143881517062138e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",21282,1863,1.37 [1.19-1.58],1.3212876374271651e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HMOX2,Heme oxygenase 2,20838,1837,1.27 [1.17-1.37],7.484836120686084e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HNMT,Histamine N-methyltransferase,21009,1839,1.23 [1.13-1.34],1.1188334502838994e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,20784,1814,0.72 [0.64-0.80],3.898432402535657e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HPSE,Heparanase,18273,1588,1.11 [1.06-1.17],6.157194081416053e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,21186,1853,1.31 [1.17-1.46],2.23645668637774e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,21282,1863,1.34 [1.22-1.48],2.1624800569974643e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,18446,1599,1.19 [1.10-1.28],2.160408462958214e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,21148,1845,1.49 [1.27-1.75],7.362002352043332e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",HYAL1,Hyaluronidase-1,21201,1850,1.69 [1.42-2.01],2.2323530372402198e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM1,Intercellular adhesion molecule 1,21210,1850,2.00 [1.76-2.27],2.546835259984649e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM3,Intercellular adhesion molecule 3,21556,1882,1.42 [1.23-1.64],2.957292923993683e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ICAM5,Intercellular adhesion molecule 5,21289,1860,1.57 [1.44-1.72],1.7765131969065549e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IDUA,Alpha-L-iduronidase,21472,1876,1.30 [1.19-1.42],5.927045190403722e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,17992,1562,1.81 [1.61-2.03],2.461732210879028e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNGR2,Interferon gamma receptor 2,21104,1848,1.25 [1.16-1.34],6.0507830628851035e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IFNLR1,Interferon lambda receptor 1,21282,1863,1.28 [1.15-1.42],4.28834788638901e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,18498,1605,0.63 [0.55-0.72],2.0986448915579057e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,21302,1865,1.80 [1.51-2.14],2.059683551656261e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,21523,1879,1.13 [1.10-1.17],3.798885734221944e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,21527,1880,1.31 [1.22-1.41],1.2146821373363395e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,21040,1846,1.70 [1.56-1.84],5.468718482429783e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,21556,1882,1.77 [1.58-1.99],3.692313672895786e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,21289,1860,1.83 [1.63-2.06],6.112365876115972e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,18488,1607,1.61 [1.43-1.81],3.1499551243414204e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,21186,1853,1.37 [1.24-1.51],6.851267846537499e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,21289,1860,1.63 [1.45-1.84],6.735605727270674e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IGSF9,Protein turtle homolog A,18494,1603,1.18 [1.12-1.24],2.907847834240272e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,21367,1868,1.64 [1.43-1.88],1.2065580837400444e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15,Interleukin-15,21282,1863,1.75 [1.55-1.99],2.6458748021056482e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,20914,1833,1.27 [1.13-1.43],6.944535193456601e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18,Interleukin-18,21191,1854,1.25 [1.14-1.37],1.262158437893223e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18BP,Interleukin-18-binding protein,21393,1864,1.47 [1.28-1.68],1.7418996181076335e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL18R1,Interleukin-18 receptor 1,21543,1879,1.32 [1.17-1.49],7.372288167433801e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL19,Interleukin-19,20757,1817,1.17 [1.11-1.23],1.0733468870069972e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R1,Interleukin-1 receptor type 1,21263,1858,1.53 [1.28-1.83],2.91412904413348e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1R2,Interleukin-1 receptor type 2,21221,1856,1.61 [1.30-1.98],9.373614434243078e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,21480,1875,1.36 [1.25-1.49],4.5376241535448476e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,20914,1833,0.72 [0.64-0.80],1.0020543267178531e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,21217,1857,1.32 [1.24-1.41],2.293909117574644e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL22,Interleukin-22,18419,1587,1.27 [1.20-1.35],2.6562140192312376e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,21147,1853,1.52 [1.39-1.67],2.660471313574346e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL32,Interleukin-32,21282,1863,1.31 [1.20-1.43],1.0773871749494176e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,21282,1863,1.64 [1.48-1.81],2.8422862765919256e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6,Interleukin-6,21186,1853,1.29 [1.24-1.33],4.067421800254431e-43
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,21289,1860,1.79 [1.42-2.28],1.377725850660147e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,21302,1865,0.83 [0.78-0.90],1.115794793778192e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",IMMT,MICOS complex subunit MIC60,18419,1587,1.43 [1.30-1.57],4.1619457618142054e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INHBB,Inhibin beta B chain,18077,1558,1.50 [1.37-1.64],1.0062355565631624e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL3,Insulin-like 3,18446,1599,0.88 [0.83-0.92],8.459151891045316e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSL5,Insulin-like peptide INSL5,18435,1602,1.16 [1.10-1.21],1.225880163804642e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",INSR,Insulin receptor,17944,1562,2.11 [1.57-2.85],9.803299082514905e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA11,Integrin alpha-11,21282,1863,0.74 [0.65-0.83],7.773694790048251e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGA5,Integrin alpha-5,21302,1865,1.71 [1.45-2.01],1.0014473146177576e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITGBL1,Integrin beta-like protein 1,18498,1605,1.48 [1.31-1.66],1.2965115185344754e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,21393,1864,1.40 [1.26-1.56],1.5317029777707015e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",JCHAIN,Immunoglobulin J chain,20914,1833,1.19 [1.11-1.27],5.121408418441717e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,21186,1853,0.79 [0.72-0.86],7.71312717850037e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KITLG,Kit ligand,21289,1860,0.61 [0.55-0.68],3.7724485926779377e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK10,Kallikrein-10,21296,1851,1.31 [1.19-1.44],6.145011623439087e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK11,Kallikrein-11,21147,1841,1.36 [1.20-1.54],1.5757152774437568e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KLK4,Kallikrein-4,21472,1876,1.28 [1.20-1.36],5.993829437570933e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",21186,1853,1.18 [1.12-1.23],3.6368160993693443e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",21245,1861,1.17 [1.11-1.24],9.37035150797924e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",17877,1545,1.12 [1.06-1.18],2.834862464460061e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",KYNU,Kynureninase,21543,1879,1.25 [1.14-1.36],7.015518330270018e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,21262,1860,1.40 [1.28-1.54],4.1828412619027753e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMA4,Laminin subunit alpha-4,21367,1868,1.34 [1.20-1.50],2.619078644142179e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,20630,1802,1.57 [1.27-1.93],2.15232552056522e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,21507,1876,1.53 [1.43-1.63],2.883335196409524e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LAYN,Layilin,21075,1846,1.45 [1.29-1.63],4.790475484873021e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LBR,Delta(14)-sterol reductase LBR,21484,1876,1.12 [1.06-1.18],3.4067011835288654e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,20655,1806,1.28 [1.16-1.42],1.773316512894721e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,18494,1603,1.21 [1.12-1.30],3.1664255020794626e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LEG1,Protein LEG1 homolog,17489,1509,1.21 [1.13-1.29],3.4855013310226344e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,18454,1594,1.22 [1.12-1.33],6.80439539882329e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS1,Galectin-1,21289,1860,1.37 [1.22-1.53],6.185537625875846e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3,Galectin-3,21351,1863,1.37 [1.20-1.58],5.066050021936826e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS3BP,Galectin-3-binding protein,18511,1612,1.65 [1.44-1.89],1.804187997367753e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS4,Galectin-4,21262,1860,1.41 [1.31-1.51],6.167118166688228e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGALS9,Galectin-9,21262,1859,1.66 [1.47-1.87],8.382829351399623e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LGMN,Legumain,21367,1868,1.58 [1.42-1.76],2.0021045287318265e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,21260,1858,1.57 [1.39-1.78],7.465412109411168e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,21556,1882,1.43 [1.23-1.66],2.178052877490233e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,21451,1873,1.35 [1.20-1.53],1.033263384945856e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,20914,1833,1.31 [1.19-1.43],1.5554995315761026e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMNB2,Lamin-B2,18446,1599,1.52 [1.28-1.80],1.7574709423251446e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LMOD1,Leiomodin-1,18454,1594,1.33 [1.18-1.51],6.000873146332103e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,18511,1612,1.83 [1.54-2.17],4.574727137629129e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,21186,1853,1.33 [1.20-1.47],3.7758982707198086e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,20914,1833,0.62 [0.56-0.69],3.5960085167693725e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,21472,1876,1.16 [1.10-1.23],3.466161294525202e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,21556,1882,1.56 [1.37-1.77],9.991999131466046e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,20784,1814,1.29 [1.20-1.38],1.1119892717575404e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,21148,1850,1.44 [1.25-1.66],3.9003328525104406e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",LY96,Lymphocyte antigen 96,21104,1848,1.42 [1.29-1.58],6.343624185041724e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,21037,1843,1.18 [1.10-1.26],2.2758831193575914e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAMDC4,Apical endosomal glycoprotein,18419,1587,1.25 [1.16-1.35],6.06075828855354e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",17992,1559,1.46 [1.21-1.76],8.483846565857145e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MARCO,Macrophage receptor MARCO,21289,1860,1.46 [1.24-1.72],3.797702168093383e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MATN2,Matrilin-2,21292,1863,1.64 [1.43-1.88],1.2695377872486474e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MDK,Midkine,21287,1853,1.36 [1.26-1.47],2.3891713348588206e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,21480,1875,1.79 [1.45-2.22],9.420876321889284e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEP1B,Meprin A subunit beta,21289,1860,0.90 [0.87-0.94],8.645546968217975e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,21262,1860,0.66 [0.56-0.78],1.0842310435795285e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MET,Hepatocyte growth factor receptor,21345,1859,0.63 [0.51-0.78],2.024039863655821e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MFGE8,Lactadherin,21302,1865,1.26 [1.15-1.37],1.705323593686887e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MME,Neprilysin,21186,1853,1.23 [1.17-1.29],3.0662300124499224e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP10,Stromelysin-2,21222,1859,1.24 [1.16-1.33],1.5538684706565549e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP12,Macrophage metalloelastase,21324,1859,1.53 [1.43-1.64],6.418627110728406e-36
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP7,Matrilysin,20877,1830,1.40 [1.29-1.53],3.5581309509312067e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP8,Neutrophil collagenase,21450,1874,1.21 [1.16-1.28],1.2597108915179766e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MMP9,Matrix metalloproteinase-9,21274,1865,1.29 [1.21-1.38],5.338702752651027e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MPO,Myeloperoxidase,21302,1865,1.19 [1.09-1.29],4.917673089043451e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MRC1,Macrophage mannose receptor 1,18509,1603,2.04 [1.74-2.40],2.7455444867576497e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSLN,Mesothelin,21151,1853,1.30 [1.23-1.36],8.514610435556264e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSMB,Beta-microseminoprotein,21267,1856,1.16 [1.09-1.23],8.1095768889848e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,21484,1876,1.37 [1.26-1.49],1.3481508425907717e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MST1,Hepatocyte growth factor-like protein,18245,1585,1.19 [1.09-1.30],8.773249959981384e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MSTN,Growth/differentiation factor 8,20906,1832,0.81 [0.75-0.87],6.73180557167171e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,18165,1571,1.19 [1.10-1.28],1.292270110466607e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MUC13,Mucin-13,20838,1837,1.17 [1.08-1.27],5.595226936357331e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MVK,Mevalonate kinase,20914,1833,1.22 [1.17-1.28],1.6185437238512374e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,21323,1866,1.45 [1.35-1.55],3.4639219762875165e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NCAN,Neurocan core protein,21484,1876,0.75 [0.67-0.83],4.3106229687015406e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NECTIN2,Nectin-2,21260,1858,1.59 [1.40-1.82],4.132424804404975e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NEFL,Neurofilament light polypeptide,20779,1831,1.34 [1.23-1.46],2.0108664213945448e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFASC,Neurofascin,21543,1879,1.47 [1.28-1.68],2.668367367389659e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",20914,1833,1.17 [1.10-1.24],2.0170898029411622e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NHLRC3,NHL repeat-containing protein 3,17655,1527,1.89 [1.61-2.21],2.041080747792106e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NME3,Nucleoside diphosphate kinase 3,21292,1863,1.53 [1.29-1.80],6.828243022807718e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NOMO1,Nodal modulator 1,21302,1865,1.59 [1.33-1.90],3.3093487315253465e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,18187,1579,1.76 [1.54-2.02],4.935623626295001e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,21289,1860,1.45 [1.28-1.64],2.443655913602968e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPL,N-acetylneuraminate lyase,18494,1603,1.27 [1.15-1.40],1.712569578677123e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPPB,Natriuretic peptides B,20906,1832,1.10 [1.07-1.14],4.647539006315003e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NPTX1,Neuronal pentraxin-1,21302,1865,1.45 [1.34-1.58],3.992086381424198e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,18446,1599,1.66 [1.44-1.92],4.10764421252775e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NT5E,5'-nucleotidase,21352,1860,1.28 [1.18-1.38],1.722656224306173e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTRK3,NT-3 growth factor receptor,21484,1876,0.68 [0.57-0.83],8.605443737441688e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,21289,1860,1.19 [1.14-1.23],3.1075013724525653e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OCLN,Occludin,18454,1594,1.96 [1.77-2.16],1.886753268996058e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,21076,1843,1.17 [1.11-1.24],2.027614484291561e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMD,Osteomodulin,21367,1868,0.74 [0.68-0.82],3.257395428872174e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,21186,1853,0.84 [0.79-0.89],7.977572354691066e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,18443,1605,2.29 [1.83-2.87],5.264925230083235e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,21292,1863,1.68 [1.49-1.89],6.066580703839952e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSM,Oncostatin-M,21175,1854,1.28 [1.21-1.35],1.9044282184730048e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,21427,1865,2.30 [1.86-2.84],1.3581697692886443e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",OXT,Oxytocin-neurophysin 1,21484,1876,1.06 [1.03-1.09],4.171706583941616e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PALM2,Paralemmin-2,18446,1599,1.84 [1.64-2.07],1.336713104404372e-24
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,21556,1882,1.33 [1.20-1.47],4.7183470755038774e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDIA3,Protein disulfide-isomerase A3,18077,1558,1.52 [1.24-1.85],4.885681984537104e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,17944,1562,1.42 [1.29-1.56],8.461910679322901e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGA4,Pepsin A-4,18509,1603,1.18 [1.10-1.27],1.7315069672683252e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGF,Placenta growth factor,21543,1879,1.58 [1.41-1.78],9.558096568824068e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,21451,1873,1.27 [1.17-1.39],7.650341553619883e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,18289,1596,1.41 [1.19-1.67],5.676259220082102e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PI3,Elafin,21012,1833,1.20 [1.12-1.29],3.295036056183724e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIGR,Polymeric immunoglobulin receptor,21029,1849,2.39 [2.16-2.63],1.942604196875392e-68
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,21302,1865,1.50 [1.30-1.73],1.9931679671873743e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,21302,1865,1.44 [1.30-1.59],6.473894473541847e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,21289,1860,1.24 [1.15-1.33],2.590868721402628e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G15,Phospholipase A2 group XV,21352,1860,2.26 [1.98-2.58],6.2969809317896495e-34
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",21264,1857,1.21 [1.13-1.30],5.9183519028222553e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAT,Tissue-type plasminogen activator,21480,1875,1.36 [1.25-1.47],2.245694836987331e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAU,Urokinase-type plasminogen activator,21302,1865,1.34 [1.16-1.56],8.133354304403274e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,21121,1852,2.69 [2.34-3.09],1.0549538089711908e-44
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLG,Plasminogen,18063,1579,1.96 [1.56-2.48],1.2079511797609132e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PLXNB2,Plexin-B2,21444,1871,1.49 [1.27-1.76],1.8665351909555413e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",21186,1853,1.28 [1.16-1.40],2.6535813693109626e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,20906,1832,1.31 [1.16-1.47],6.253233918747867e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPL,Periplakin,17944,1562,1.41 [1.21-1.63],6.387507661826619e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,18454,1594,1.27 [1.14-1.41],1.4987243681663809e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRAP1,Proline-rich acidic protein 1,18498,1605,1.59 [1.39-1.81],2.418197914492609e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,21425,1869,1.57 [1.38-1.78],4.380080219981997e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PREB,Prolactin regulatory element-binding protein,20914,1833,1.32 [1.15-1.51],5.429516855128715e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS2,Trypsin-2,21393,1864,1.32 [1.24-1.40],1.6156031586843405e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS22,Brain-specific serine protease 4,17944,1562,1.31 [1.18-1.46],8.160083383960934e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PRSS8,Prostasin,21188,1857,1.96 [1.79-2.15],6.727017956731066e-47
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PSAP,Prosaposin,18332,1593,1.71 [1.45-2.00],5.0258740813664946e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,18494,1603,1.57 [1.37-1.81],1.9668072911665582e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PTX3,Pentraxin-related protein PTX3,21282,1863,1.22 [1.11-1.33],1.3382887952150667e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",PVR,Poliovirus receptor,21484,1876,1.60 [1.44-1.76],4.467113503961564e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",QSOX1,Sulfhydryl oxidase 1,18147,1576,1.28 [1.18-1.39],4.731371734380714e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,21427,1865,1.32 [1.22-1.43],1.1459103938782258e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,18454,1594,1.44 [1.29-1.61],5.400093291860273e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP2,Retinol-binding protein 2,21186,1853,1.17 [1.11-1.23],4.947459287813322e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP5,Retinol-binding protein 5,21186,1853,1.32 [1.23-1.42],3.955197199440054e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RBP7,Retinoid-binding protein 7,18435,1602,1.16 [1.09-1.24],5.683984245114418e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1A,Lithostathine-1-alpha,21181,1846,1.30 [1.21-1.41],3.0412288973010814e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG1B,Lithostathine-1-beta,21556,1882,1.24 [1.16-1.32],5.103191731555311e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,21556,1882,1.20 [1.13-1.27],4.665485776730256e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REG4,Regenerating islet-derived protein 4,21292,1863,1.40 [1.30-1.52],8.385932744007088e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,21302,1865,1.54 [1.35-1.77],5.002991633911197e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",REN,Renin,21289,1860,1.17 [1.11-1.23],1.6119847599191522e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RGMA,Repulsive guidance molecule A,21484,1876,0.74 [0.65-0.84],4.262568422701298e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE1,Ribonuclease pancreatic,18509,1603,1.82 [1.50-2.20],7.287844765775495e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE4,Ribonuclease 4,17924,1555,1.56 [1.31-1.86],6.825904217752372e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASE6,Ribonuclease K6,18389,1595,1.48 [1.28-1.71],1.0007096206465525e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNASET2,Ribonuclease T2,21461,1872,1.50 [1.29-1.74],7.065390320113804e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,17992,1559,1.73 [1.48-2.01],1.876268347551792e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,20784,1814,1.22 [1.13-1.32],2.746498179452663e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",RSPO1,R-spondin-1,21104,1848,1.55 [1.37-1.74],4.406138764404712e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",S100A11,Protein S100-A11,21126,1846,1.19 [1.10-1.28],9.662064883635174e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARB2,Lysosome membrane protein 2,20690,1804,1.60 [1.40-1.82],1.2901904946093113e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCARF2,Scavenger receptor class F member 2,21484,1876,1.35 [1.16-1.57],9.05955916905159e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB1A1,Uteroglobin,21297,1864,0.81 [0.76-0.86],8.896476802290272e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,18077,1558,1.81 [1.53-2.15],1.1598180640585199e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,21336,1865,1.17 [1.12-1.22],1.7565966855557925e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SCLY,Selenocysteine lyase,21418,1871,1.37 [1.26-1.49],6.753515063294168e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELE,E-selectin,21556,1882,1.36 [1.25-1.48],1.964722415889547e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SELENOP,Selenoprotein P,18511,1612,0.54 [0.43-0.67],2.5276546795046948e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN3,Neuronal-specific septin-3,18454,1594,1.14 [1.07-1.22],3.212106336188818e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SEPTIN8,Septin-8,18412,1594,1.59 [1.40-1.80],5.968414602134719e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA1,Alpha-1-antitrypsin,18177,1582,3.10 [2.06-4.66],5.951301126898096e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA11,Serpin A11,21556,1882,1.25 [1.13-1.38],1.189666685141015e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,18459,1607,2.62 [2.04-3.37],4.0958769402215485e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA6,Corticosteroid-binding globulin,18511,1612,2.00 [1.48-2.69],5.122582244602673e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINA9,Serpin A9,21099,1848,1.11 [1.05-1.17],8.189097319993382e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINB8,Serpin B8,21543,1879,1.12 [1.06-1.19],4.4635349792636414e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPIND1,Heparin cofactor 2,18483,1611,1.69 [1.43-2.00],7.259146580527672e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,21556,1882,1.17 [1.10-1.25],3.868761528498425e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SERPING1,Plasma protease C1 inhibitor,18483,1611,2.59 [2.00-3.36],6.578593686675116e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP1,Secreted frizzled-related protein 1,21024,1837,1.24 [1.13-1.36],3.406159523891633e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFRP4,Secreted frizzled-related protein 4,18077,1558,0.77 [0.68-0.88],6.729429325454795e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,20784,1814,1.19 [1.12-1.27],1.7317785034252263e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,20784,1814,1.30 [1.23-1.38],4.157160826761378e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,18201,1572,1.19 [1.10-1.29],1.2909642570960772e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SHISA5,Protein shisa-5,18498,1605,1.90 [1.59-2.27],2.560675690885647e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIAE,Sialate O-acetylesterase,21315,1859,1.24 [1.14-1.35],8.782816690675777e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC1,Sialoadhesin,21367,1868,1.41 [1.28-1.55],1.4731789674716045e-12
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,21282,1863,1.37 [1.21-1.54],2.63229348978255e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,21289,1860,1.98 [1.71-2.29],1.6921629620228718e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,17992,1559,1.32 [1.18-1.47],9.428619382016736e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,21222,1856,1.19 [1.09-1.29],9.231784643708748e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,20914,1833,1.18 [1.10-1.26],5.609704479220261e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF7,SLAM family member 7,21282,1863,1.21 [1.13-1.28],7.047319169164821e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLAMF8,SLAM family member 8,20784,1814,1.23 [1.13-1.33],1.050502594916358e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A14,Zinc transporter ZIP14,20838,1837,1.30 [1.16-1.46],1.2451718700416071e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLC39A5,Zinc transporter ZIP5,21282,1863,1.17 [1.08-1.26],8.04450668678147e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,17944,1562,0.65 [0.56-0.76],1.1470407464315564e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,21472,1876,0.73 [0.66-0.81],3.88758871236522e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,18435,1602,1.15 [1.08-1.22],9.72527162102273e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,21381,1862,1.45 [1.35-1.55],1.0487121896019071e-26
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,21327,1864,1.22 [1.15-1.30],6.093948448714408e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SMTN,Smoothelin,18409,1596,1.12 [1.06-1.18],1.6850628311044665e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',18446,1599,1.18 [1.09-1.28],4.947912865673035e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",21302,1865,1.47 [1.33-1.63],1.354434661920746e-13
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SORT1,Sortilin,21260,1858,1.27 [1.14-1.41],1.2676275177756334e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,21302,1865,1.56 [1.42-1.72],5.190459504886741e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,18077,1558,1.32 [1.16-1.51],4.04648600536248e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,21282,1863,1.14 [1.07-1.21],6.353442194662002e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,21221,1856,1.84 [1.59-2.13],3.60667352080942e-16
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON1,Spondin-1,21292,1863,1.73 [1.54-1.93],2.971721036479176e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPON2,Spondin-2,21186,1851,1.82 [1.61-2.05],1.0243012219333925e-22
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SPP1,Osteopontin,21527,1880,1.26 [1.15-1.37],1.826534502240293e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,21260,1858,0.84 [0.81-0.87],7.94471309299198e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,21393,1864,1.22 [1.11-1.34],3.6611552056023e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",21556,1882,1.69 [1.49-1.91],6.712644133062566e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STAB2,Stabilin-2,18498,1605,1.63 [1.38-1.93],8.439924528984384e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",STC1,Stanniocalcin-1,21484,1876,1.26 [1.16-1.36],4.035641302572639e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SULT2A1,Bile salt sulfotransferase,21282,1863,1.27 [1.20-1.34],1.4164958219169914e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD2,Sushi domain-containing protein 2,21302,1865,1.65 [1.47-1.85],2.5135439703454328e-17
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",SUSD5,Sushi domain-containing protein 5,17994,1552,0.74 [0.65-0.85],1.3486152213325671e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,21186,1853,1.35 [1.21-1.51],7.568066378900482e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCN2,Transcobalamin-2,21527,1880,1.45 [1.27-1.66],5.4533356516302074e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCOF1,Treacle protein,18494,1603,1.27 [1.13-1.44],9.44194521039537e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TCTN3,Tectonic-3,18494,1603,1.63 [1.40-1.89],1.6395091541524268e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF1,Trefoil factor 1,21207,1860,1.23 [1.18-1.29],3.576823880841489e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF2,Trefoil factor 2,21336,1865,1.50 [1.41-1.59],3.26981139871573e-38
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFF3,Trefoil factor 3,21286,1847,1.46 [1.33-1.60],5.160589228283567e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI,Tissue factor pathway inhibitor,21250,1853,1.35 [1.19-1.53],3.726061349929068e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,21294,1853,1.27 [1.18-1.37],4.643913149944e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFA,Protransforming growth factor alpha,21282,1863,1.41 [1.31-1.51],2.474243860196751e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,21507,1876,1.36 [1.23-1.50],2.080959967188673e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,21182,1846,1.45 [1.24-1.70],2.753678780751186e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TGFBR2,TGF-beta receptor type-2,21352,1860,1.35 [1.20-1.52],6.380882266960723e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THBS2,Thrombospondin-2,21302,1865,1.68 [1.51-1.87],1.1433014270253737e-21
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",THOP1,Thimet oligopeptidase,21189,1855,1.39 [1.23-1.57],2.255437928890863e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,21081,1833,1.96 [1.70-2.26],3.1740637026039764e-20
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,21302,1865,1.75 [1.60-1.91],4.2331322628680515e-35
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,18412,1594,1.39 [1.23-1.57],1.579110135152627e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TMSB10,Thymosin beta-10,21302,1865,1.11 [1.06-1.17],8.410459932828322e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNC,Tenascin,21393,1864,1.25 [1.15-1.36],4.180220706058246e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNF,Tumor necrosis factor,20880,1828,1.26 [1.12-1.40],5.240357787964952e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,21104,1848,1.83 [1.62-2.06],1.3470983204878608e-23
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,21104,1848,1.70 [1.66-1.75],0.0
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21543,1879,1.30 [1.17-1.44],5.197739089332935e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,21262,1860,1.93 [1.72-2.16],7.575504619659171e-30
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,21352,1860,1.66 [1.48-1.85],1.5800169478525725e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,21292,1863,1.28 [1.16-1.43],3.386681838965541e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,21292,1863,1.40 [1.23-1.60],3.993093861720141e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,21302,1865,1.78 [1.57-2.03],1.88126659514338e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,21302,1865,1.44 [1.31-1.59],5.04389880500512e-14
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,21484,1876,1.35 [1.17-1.56],2.9594094423276898e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,21104,1848,1.40 [1.31-1.49],2.6946268776999744e-25
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,21104,1848,1.27 [1.16-1.39],2.650801740418938e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,21282,1863,0.81 [0.76-0.86],3.420385061620471e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,21543,1879,0.67 [0.58-0.77],2.5778532302242136e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,21367,1868,1.63 [1.41-1.88],5.2330831824955e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,21521,1879,1.88 [1.64-2.16],1.0983267168053396e-19
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TNR,Tenascin-R,21104,1848,0.67 [0.61-0.74],4.123554645436096e-15
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TPP1,Tripeptidyl-peptidase 1,21124,1852,1.50 [1.40-1.61],4.687438749375709e-31
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,21262,1860,1.47 [1.37-1.58],9.029777978915578e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN7,Tetraspanin-7,17877,1545,0.88 [0.83-0.94],6.55606874113328e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TSPAN8,Tetraspanin-8,18435,1602,1.13 [1.08-1.19],1.2801624781272986e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,21352,1860,1.60 [1.38-1.86],2.874130623493106e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",TYMP,Thymidine phosphorylase,21159,1850,1.13 [1.07-1.21],5.821177532079018e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ULBP2,UL16-binding protein 2,21104,1848,1.37 [1.23-1.52],2.8019199337345704e-09
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",UMOD,Uromodulin,21479,1874,0.82 [0.76-0.88],5.0490778235060266e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,20906,1832,1.29 [1.20-1.39],1.1318753353455425e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VCAN,Versican core protein,21484,1876,1.31 [1.15-1.49],5.589054371550472e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFA,Vascular endothelial growth factor A,21472,1872,1.21 [1.13-1.30],2.7731502468053886e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VEGFD,Vascular endothelial growth factor D,21512,1876,1.26 [1.12-1.40],6.722625384685252e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,21186,1853,1.21 [1.11-1.32],2.0345590895490943e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,17856,1551,1.34 [1.18-1.53],1.2678580842244315e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,18419,1587,1.28 [1.19-1.37],3.6313826250368857e-11
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,21273,1858,1.55 [1.40-1.71],5.794145320740927e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VSNL1,Visinin-like protein 1,18446,1599,1.26 [1.14-1.39],6.701430506236496e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,21448,1875,1.63 [1.50-1.78],3.287985869851629e-28
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",VWC2,Brorin,21035,1842,1.24 [1.12-1.37],2.1674970608737903e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",21302,1865,1.30 [1.16-1.45],4.855530969319645e-06
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,21428,1871,1.19 [1.12-1.27],3.806290206765087e-08
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,20247,1746,1.93 [1.78-2.10],2.488928804817489e-53
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",21027,1843,0.64 [0.58-0.71],1.618368323592654e-18
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WIF1,Wnt inhibitory factor 1,21472,1876,1.36 [1.21-1.52],1.5753661791989017e-07
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",WNT9A,Protein Wnt-9a,20914,1833,1.34 [1.16-1.55],9.526035795140074e-05
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",YAP1,Transcriptional coactivator YAP1,18446,1599,1.73 [1.45-2.06],6.019736290344794e-10
Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,20906,1832,1.22 [1.12-1.33],3.6425977263754415e-06
